Branded

Endo's Fortesta receives FDA approval
Jan 04, 2011
The Food and Drug Administration has approved a topical testosterone...
more
Drug approvals low in 2010
Jan 03, 2011
This past year saw a lower-than-usual number of new drugs approved by the...
more
New strength of Intelence gets regulatory approval
Jan 03, 2011
The Food and Drug Administration has approved an update to the label of a...
more
George W. Bush to deliver keynote speech at Armada summit
Jan 03, 2011
Former president George W. Bush will deliver the keynote speech at Armada...
more
FDA rejection of lower-dose Copaxone will likely ward off generic competition
Dec 29, 2010
Recent news that the FDA has rejected Teva's application for a new lower-...
more
Cephalon appoints new CEO
Dec 23, 2010
Cephalon on Thursday appointed Kevin Buchi as CEO and a member of the...
more
FDA approves Watson oral contraceptive
Dec 23, 2010
The Food and Drug Administration has approved the first and only low-dose...
more

PATIENT VIEWS

Health benefits important to personal product purchasers
Health benefits are among the top characteristics playing a role in personal...

MORE PATIENT VIEWS >

VIDEO

HHS Secretary Sebelius speaks at CVS/pharmacy, MinuteClinic about new Medicare benefits
CVS Caremark and the Centers for Medicare and Medicaid Services have teamed up...

PHARMACIST CE

March/April 2013
Advancing the management of hepatitis C

Treatment options for patients with irritable bowel syndrome

COLLABORATIVE CARE E-NEWSLETTER

Get the latest news in retail health with the DSN Collaborative Care E-Newsletter. Product news, clinical updates, patient health information — everything you need to stay on top of your industry.

Sign up for free here!

PHARMACY AFFAIRS

Walgreens omnichannel evolution in pharmacy
DSN recently sat down with Suzanne Hansen, Walgreens group VP pharmacy...

VIDEO

Introducing Pharmacist Society powered by Drug Store News
Pharmacist Society powered by Drug Store News is a customizable social media...
© 2013 Drug Store News. All Rights Reserved.